BSEInsider Trading / SAST10h ago · 26 Oct 2026, 04:14 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shivalik Rasayan Ltd & Growel Remedies Ltd
Medicamen Biotech Ltd-$ · 531146
✦ AI SummaryRelated Party
Medicamen Biotech Ltd has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, related to substantial acquisition of shares by Shivalik Rasayan Ltd and Growel Remedies Ltd.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment3/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medicamen Biotech Ltd-$ - 531146 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011